{"clarifying_information": [{"clarifying_question1": "Are you mainly interested in phage display-derived antibodies used for pathogen detection (e.g., bacteria, viruses, or toxins) or also in their applications for disease biomarker identification (such as cancer markers)?", "clarifying_answer1": {"clarifying_answer": "I am interested in both pathogen detection and disease biomarker identification (including cancer markers) applications of phage display-derived antibodies in diagnostics."}}, {"clarifying_question2": "Would you like a focus on specific diagnostic platforms or assay formats (e.g., ELISA, biosensors, immuno-PCR, lateral flow assays) where phage display-derived antibodies are most commonly used?", "clarifying_answer2": {"clarifying_answer": "Yes, please focus on the most commonly used diagnostic platforms and assay formats (such as ELISA, biosensors, immuno-PCR, and lateral flow assays) where phage display-derived antibodies are applied in biomedical diagnostics."}}, {"clarifying_question3": "Are you seeking information about the advantages of phage display-derived antibodies over traditional antibodies specifically in diagnostic applications, including aspects like speed, specificity, and adaptability?", "clarifying_answer3": {"clarifying_answer": "Yes, I would like information focused on the advantages of phage display-derived antibodies over traditional antibodies specifically in diagnostic applications, including aspects like speed, specificity, and adaptability."}}], "better_queries_2": {"reformulated1": "What are the most common diagnostic applications of phage display-derived antibodies for both pathogen detection and disease biomarker identification (including cancer markers), and which assay platforms (e.g., ELISA, biosensors, immuno-PCR, lateral flow assays) are these antibodies most frequently utilized in?", "reformulated2": "In biomedical diagnostics, how do phage display-derived antibodies compare to traditional antibodies in commonly used assay formats (such as ELISA, biosensors, immuno-PCR, and lateral flow assays) regarding their speed of development, specificity, and adaptability, particularly for pathogen and disease biomarker detection?", "reformulated3": "Please summarize the principal uses and advantages of phage display-derived antibodies versus traditional antibodies within major diagnostic platforms (ELISA, biosensors, immuno-PCR, lateral flow) for both pathogen (bacteria, viruses, toxins) and disease biomarker (e.g., cancer marker) detection in biomedicine."}}
